Company profile
Atlantic International Corp
NASDAQ: CIRC · Healthcare · Medical - Pharmaceuticals
#222 of 1,418 Healthcare companies by revenue39th-percentile growth
EA Score
50DFH 51DQ —GM 46SS 51
v0.1 · 45/100 weight · provisional
↑ 3-yr revenue growth, workforce scale · ↓ growth stability, listing tenure
Methodology →Revenue TTM
$799.9M
Rev growth YoY (TTM)
+80.5%
Net income (FY)
-$59.4M
Employees
300
as of 2026-08-03
Market cap
$64.5M
as of 2026-08-03
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$435.9M$435.9M2025
Net income-$59.4M-$59.4M2025
Operating income-$50.2M-$50.2M2025
Total assets$113.2M$113.2M2025
Liabilities$145.3M$145.3M2025
Equity-$32.1M-$32.1M2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Atlantic International Corp’s revenue?
Atlantic International Corp booked $435.9M in FY2025 revenue, contracting 1.5% year over year — slower than 61% of Healthcare companies we track, at a -13.6% net margin.
Peers · Healthcare
PMV Pharmaceuticals, Inc.——OS Therapies Incorporated——Citius Oncology, Inc.——Boundless Bio, Inc.——MindWalk Holdings Corp.——MiNK Therapeutics, Inc.——Neighbors
Bergen →Key facts
CEOGuus Franke
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersEnglewood Cliffs, NJ
ExchangeNASDAQ: CIRC
Employees300
IPO date2021-08-27
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.